A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with β-thalassaemia

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 589-592

  Salsaa, B ^a   Zoumbos, N C ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cytokines; Transfusions; thalassaemia

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; HUMAN; HUMAN CELL; INFECTION; PRIORITY JOURNAL;

EID: 0031041199     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-962.x     Document Type: Article

References (12)

1. Yuan J, Angelucci E, Lucarelli G et al. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe β-thalassemia (Cooley's anemia). Blood 1993; 82:374-7.
2. Martino M, Rossi ME, Resti M, Vullo C, Vierucci A. Changes in superoxide anion production in neutrophis from multitransfused β-thalassemia patients: correlation with ferritin levels and liver damage. Acta Haematol 1984; 71:289-95.
3. Ballart IJ, Estevez ME, Sen L, Diez RA, Giuntoli J, De Miani SA, Penalver J. Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major. Blood 1986; 67:105-9.
4. Guglielmo P, Cunsolo F, Lombardo T, Sortino J, Giustolisi R, Cacciola E, Cacciola E. T subset abnormalities in thalassemia intermedia: possible evidence of a thymus functional deficiency. Acta Haematol 1984; 72:361-7.
5. Dwyer J, Wood C, McNamara J et al. Abnormalities in the immune system of children with beta-thalassemia major. Clin Exp Immunol 1987; 68:621-9.
6. Pardalos G, Kanakoudi-Tsakalidis F, Malaka-Zafiriu M, Tsantali H, Athanasiou-Metaxa M, Kalinikos G, Papaevangelou G. Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major. Clin Exp Immunol 1987; 68:138-45.
7. Neri A, Brugiatelli M, Iacopino P, Callea V, Ronco F. Natural killer cell activity and T subpopulations in thalassemia major. Acta Haematol 1984; 71:263-9.
8. Akbar A, Fitzgerald-Bocarsly A, De Sousa M, Giardina P, Hilgartner M, Grady R. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload. J Immunol 1986; 136:1635-40.
9. Lombardi G, Matera R, Minervini MM et al. Serum levels of cytokines and soluble antigens in polytransfused patients with beta thalassemia major. Haematologica 1994; 79:406-12.
10. Nielsen P, Fisher R, Engelhardt R, Tondury P, Gabbe EE, Janka GE. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferioxamine or deferiprone. Br J Haematol 1995; 91:827-33.
11. Zoumbos N, Gascon P, Djeu J, Young N. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 1985; 82:188-92.
12. Johnson C, Cook C, Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-α (TNFα): reversal with exogenous erythropoietin. Exp Hematol 1990; 18:109-13.